• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

35.63 +0.69 (+1.97%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vericel Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
Vericel Corp (NASDAQ: VCEL) Posts Mixed Q2 2025 Results with Revenue Miss and EPS Beat
July 31, 2025
Vericel Corp (VCEL) posted mixed Q2 2025 results with revenue missing estimates but EPS beating expectations. Shares fell 6.5% pre-market despite strong MACI growth and margin expansion. 
Via Chartmill
Vericel Reports Second Quarter 2025 Financial Results
July 31, 2025
From Vericel Corporation
Via GlobeNewswire
Earnings Scheduled For July 31, 2025
July 31, 2025
 
Via Benzinga
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
July 17, 2025
From Vericel Corporation
Via GlobeNewswire
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential
July 02, 2025
VERICEL CORP (NASDAQ:VCEL) shows strong growth fundamentals and a technical breakout pattern, making it a stock to watch in the biotech sector. 
Via Chartmill
Earnings Scheduled For May 8, 2025
May 08, 2025
 
Via Benzinga
Where Vericel Stands With Analysts
February 28, 2025
 
Via Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
 
Via Benzinga
What 7 Analyst Ratings Have To Say About Vericel
February 03, 2025
 
Via Benzinga
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
June 10, 2025
From Vericel Corporation
Via GlobeNewswire
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with Technical Breakout Potential
June 06, 2025
VERICEL CORP (NASDAQ:VCEL) shows strong revenue and earnings growth, backed by a solid balance sheet and a promising technical breakout pattern. 
Via Chartmill
What Analysts Are Saying About Vericel Stock
May 22, 2025
 
Via Benzinga
VERICEL CORP (NASDAQ:VCEL) – A Strong Growth Stock with a Technical Setup
May 16, 2025
VERICEL CORP (NASDAQ:VCEL) shows strong growth potential with solid profitability and a promising technical setup, making it a stock worth watching. 
Via Chartmill
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
May 08, 2025
From Vericel Corporation
Via GlobeNewswire
Beyond The Numbers: 5 Analysts Discuss Vericel Stock
January 15, 2025
 
Via Benzinga
Earnings Preview For Vericel
November 06, 2024
 
Via Benzinga
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
August 27, 2024
 
Via Benzinga
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
May 07, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at Multiple Upcoming Investor Conferences
March 04, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
February 27, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
February 13, 2025
From Vericel Corporation
Via GlobeNewswire
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 15, 2025
 
Via Benzinga
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
January 14, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
January 08, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel Stock Sees RS Rating Shoot Higher
November 11, 2024
The Relative Strength (RS) Rating for Vericel stock entered a higher percentile Monday, as it got a lift from 69 to 79. 
Via Investor's Business Daily
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
Vericel Reports Third Quarter 2024 Financial Results
November 07, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
October 24, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
August 29, 2024
From Vericel Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap